These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35633070)

  • 1. SUMOylation does not affect cardiac troponin I stability but alters indirectly the development of force in response to Ca
    Fertig B; Ling J; Nollet EE; Dobi S; Busiau T; Ishikawa K; Yamada K; Lee A; Kho C; Wills L; Tibbo AJ; Scott M; Grant K; Campbell KS; Birks EJ; MacQuaide N; Hajjar R; Smith GL; van der Velden J; Baillie GS
    FEBS J; 2022 Oct; 289(20):6267-6285. PubMed ID: 35633070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific acetyl-mimetic modification of cardiac troponin I modulates myofilament relaxation and calcium sensitivity.
    Lin YH; Schmidt W; Fritz KS; Jeong MY; Cammarato A; Foster DB; Biesiadecki BJ; McKinsey TA; Woulfe KC
    J Mol Cell Cardiol; 2020 Feb; 139():135-147. PubMed ID: 31981571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
    Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
    Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling of myofilament Ca2+ sensitivity from troponin I phosphorylation by mutations can be reversed by epigallocatechin-3-gallate.
    Papadaki M; Vikhorev PG; Marston SB; Messer AE
    Cardiovasc Res; 2015 Oct; 108(1):99-110. PubMed ID: 26109583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation.
    Salhi HE; Walton SD; Hassel NC; Brundage EA; de Tombe PP; Janssen PM; Davis JP; Biesiadecki BJ
    J Mol Cell Cardiol; 2014 Nov; 76():257-64. PubMed ID: 25252176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolutionarily conserved C-terminal peptide of troponin I is an independently configured regulatory structure to function as a myofilament Ca
    Wong S; Feng HZ; Jin JP
    J Mol Cell Cardiol; 2019 Nov; 136():42-52. PubMed ID: 31505197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventricular differences in myofilament function in experimental congestive heart failure.
    Belin RJ; Sumandea MP; Sievert GA; Harvey LA; Geenen DL; Solaro RJ; de Tombe PP
    Pflugers Arch; 2011 Dec; 462(6):795-809. PubMed ID: 21927813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I).
    Warren CM; Karam CN; Wolska BM; Kobayashi T; de Tombe PP; Arteaga GM; Bos JM; Ackerman MJ; Solaro RJ
    Circ Cardiovasc Genet; 2015 Dec; 8(6):765-73. PubMed ID: 26553696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin I.
    Vikhorev PG; Song W; Wilkinson R; Copeland O; Messer AE; Ferenczi MA; Marston SB
    Biophys J; 2014 Nov; 107(10):2369-80. PubMed ID: 25418306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troponin I Tyrosine Phosphorylation Beneficially Accelerates Diastolic Function.
    Salyer LG; Salhi HE; Brundage EA; Shettigar V; Sturgill SL; Zanella H; Templeton B; Abay E; Emmer KM; Lowe J; Rafael-Fortney JA; Parinandi N; Foster DB; McKinsey TA; Woulfe KC; Ziolo MT; Biesiadecki BJ
    Circ Res; 2024 Jan; 134(1):33-45. PubMed ID: 38095088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac myosin regulatory light chain kinase modulates cardiac contractility by phosphorylating both myosin regulatory light chain and troponin I.
    Sevrieva IR; Brandmeier B; Ponnam S; Gautel M; Irving M; Campbell KS; Sun YB; Kampourakis T
    J Biol Chem; 2020 Apr; 295(14):4398-4410. PubMed ID: 32086378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations.
    Sparrow AJ; Sievert K; Patel S; Chang YF; Broyles CN; Brook FA; Watkins H; Geeves MA; Redwood CS; Robinson P; Daniels MJ
    Circ Res; 2019 Apr; 124(8):1228-1239. PubMed ID: 30732532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils.
    Iorga B; Blaudeck N; Solzin J; Neulen A; Stehle I; Lopez Davila AJ; Pfitzer G; Stehle R
    Cardiovasc Res; 2008 Mar; 77(4):676-86. PubMed ID: 18096573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimera analysis of troponin I domains that influence Ca(2+)-activated myofilament tension in adult cardiac myocytes.
    Westfall MV; Albayya FP; Turner II; Metzger JM
    Circ Res; 2000 Mar; 86(4):470-7. PubMed ID: 10700453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation.
    Wijnker PJ; Sequeira V; Foster DB; Li Y; Dos Remedios CG; Murphy AM; Stienen GJ; van der Velden J
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1171-81. PubMed ID: 24585778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function.
    Nixon BR; Thawornkaiwong A; Jin J; Brundage EA; Little SC; Davis JP; Solaro RJ; Biesiadecki BJ
    J Biol Chem; 2012 Jun; 287(23):19136-47. PubMed ID: 22493448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
    Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
    Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased myofilament calcium sensitivity is associated with decreased cardiac troponin I phosphorylation in the diabetic rat heart.
    Greenman AC; Diffee GM; Power AS; Wilkins GT; Gold OMS; Erickson JR; Baldi JC
    Exp Physiol; 2021 Nov; 106(11):2235-2247. PubMed ID: 34605091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal phosphorylation of cardiac troponin-I reduces length-dependent calcium sensitivity of contraction in cardiac muscle.
    Rao VS; Korte FS; Razumova MV; Feest ER; Hsu H; Irving TC; Regnier M; Martyn DA
    J Physiol; 2013 Jan; 591(2):475-90. PubMed ID: 23129792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKC-betaII sensitizes cardiac myofilaments to Ca2+ by phosphorylating troponin I on threonine-144.
    Wang H; Grant JE; Doede CM; Sadayappan S; Robbins J; Walker JW
    J Mol Cell Cardiol; 2006 Nov; 41(5):823-33. PubMed ID: 17010989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.